Topical Finasteride for Hair Restoration

Hair RestorationTopical Finasteridebased on 2 studiesLast updated: 2026-04
Every claim on this page traces to a named peer-reviewed study listed in the Research section below.

What is Topical Finasteride for hair loss?

Topical finasteride is finasteride applied directly to the scalp as a spray, gel, or solution rather than taken as a tablet. The rationale is that scalp application reduces how much finasteride is absorbed into the bloodstream, which may lower the risk of sexual side effects compared to the oral form. Topical finasteride is not FDA-approved. In the US, all topical finasteride products are compounded by pharmacies and prescribed off-label. The FDA issued an adverse event communication about compounded topical finasteride in 2024. An approved topical finasteride spray is available in some European countries.

Does Topical Finasteride work for hair loss?

Yes, with a similar effect size to oral finasteride, but it is not FDA-approved. A Phase III trial of 458 men found topical finasteride spray significantly increased hair count compared to placebo, with an effect similar to oral finasteride. A 2018 systematic review of 7 studies found all reported significant decreases in hair loss and increases in hair count. Topical application results in markedly lower systemic DHT suppression than oral finasteride, which may reduce side effect risk. This has not been confirmed in a large controlled safety trial.

Who it applies to

  • Men with pattern hair loss seeking lower systemic exposure than oral finasteride
  • Prescription only, compounded in the US
  • FDA adverse event communication issued 2024 (requires informed discussion with a prescribing doctor)

Who it does not apply to

  • Women of childbearing age (same contraindication as oral finasteride)
  • People looking for an OTC or non-prescription option
  • People in markets without access to a compounding pharmacy

What to look for when buying

Every spec brands use in marketing — and what the research actually says.

What brands marketResearch verdictWhat to look for
Efficacy vs placebo MattersTopical finasteride significantly increased hair count vs placebo in a Phase III trial (458 men, 24 weeks). Effect size similar to oral finasteride.
Systemic DHT reduction MattersTopical application results in significantly lower systemic DHT suppression than oral finasteride. Scalp DHT still reduced significantly. Whether this translates to fewer sexual side effects has not been confirmed in a large controlled safety trial.
FDA status MattersNot FDA-approved. All US products are compounded. FDA issued adverse event communication in 2024.
Combined with minoxidil MattersA 2025 meta-analysis of 7 RCTs found combining topical finasteride with topical minoxidil produced significantly better results than minoxidil alone on hair density and diameter.
Concentration and formulation⚠️ UnclearStudies have used varying concentrations (0.005% to 1%). No standardised formulation is FDA-approved in the US.

What research cannot tell you

These questions are not answered by any qualified study in our database.

  • Whether topical finasteride causes fewer sexual side effects than oral finasteride in a large controlled trial
  • The optimal concentration or formulation
  • Long-term safety and efficacy beyond 24 weeks
  • Whether results apply equally to women (most evidence is from male participants)

Research behind this page

All studies are independent systematic reviews or meta-analyses.

StudyScoreFinding
Topical finasteride spray Phase III trial
7/10
Significant hair count increase vs placebo; similar effect to oral finasteride; markedly lower systemic DHT suppression
Topical finasteride across 7 studies
5/10
All 7 studies reported significant decreases in hair loss rate and increases in hair count; much lower systemic DHT reduction than oral

What the research says about common buyer questions

Does it work as well as oral finasteride?+

The Phase III trial found a similar effect size to oral finasteride for hair count at 24 weeks. The systemic DHT reduction was much lower with topical application. Both findings are consistent with the expectation that a lower absorbed dose would have a similar scalp effect but less systemic impact.

Does it cause fewer sexual side effects?+

Research cannot confirm this. The lower systemic DHT suppression is documented, but no large controlled trial has directly compared sexual side effect rates between topical and oral finasteride. The assumption that lower systemic exposure means fewer side effects is reasonable but unconfirmed.

Is it safe?+

The FDA issued an adverse event communication about compounded topical finasteride in 2024. This communication identified adverse events reported by users. Any use requires discussion with a prescribing doctor who is aware of this communication.

Does it work better combined with minoxidil?+

Yes, based on available evidence. A 2025 meta-analysis of 7 RCTs found the combination of topical finasteride and topical minoxidil significantly outperformed minoxidil alone on hair density, hair diameter, and photographic assessment.